Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2)
The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
The medicinal chemistry and preclinical biology of imidazopyridine-based inhibitors of diacylglycerol acyltransferase 2 (DGAT2) is described. A screening hit 1 with low lipophilic efficiency (LipE) was optimized through two key structural modifications: (1) identification of the pyrrolidine amide group for a significant LipE improvement, and (2) insertion of a sp(3)-hybridized carbon center in the core of the molecule for simultaneous improvement of N-glucuronidation metabolic liability and off-target pharmacology. The preclinical candidate 9 (PF-06424439) demonstrated excellent ADMET properties and decreased circulating and hepatic lipids when orally administered to dyslipidemic rodent models.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Escape from Flatland 2: complexity and promiscuity
Lovering, F. (2013) · MedChemComm · doi:10.1039/c2md20347b · Cited by 1,444
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Thematic review series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis
Yen, C.-L. E., Stone, S. J., Koliwad, S., Harris, C., & Farese, R. V. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800018-jlr200 · Cited by 1,105
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
The TG and HDL Working Group of the Exome Sequencing Project, N. H. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1307095 · Cited by 1,071
Rapid separation of lipid classes in high yield and purity using bonded phase columns.
Kaluzny, M. A., Duncan, L. A., Merritt, M. V., & Epps, D. E. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34412-6 · Cited by 964
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308027 · Cited by 919
Common variants associated with plasma triglycerides and risk for coronary artery disease
Do, R., Willer, C. J., Schmidt, E. M., Sengupta, S., Gao, C., Peloso, G. M., Gustafsson, S., Kanoni, S., Ganna, A., Chen, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2795 · Cited by 862
Research works printed but not linked: 1
- Guillaume D., 1994, Bull. Soc. Chim. Fr., 131, 391
Cited by
Highly accurate protein structure prediction for the human proteome
Tunyasuvunakool, K., Adler, J., Wu, Z., Green, T., Zielinski, M., Žídek, A., Bridgland, A., Cowie, A., Meyer, C., Laydon, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03828-1 · Cited by 3,025
Talele, T. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00472 · Cited by 1,023
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745
“specifically regulating the incorporation of arachidonic acid into phosphatidylinositol (Gijón et al., 2008).”
Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress
Cheng, X., Geng, F., Pan, M., Wu, X., Zhong, Y., Wang, C., Tian, Z., Cheng, C., Zhang, R., Puduvalli, V., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.002 · Cited by 347
APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia
Sienski, G., Narayan, P., Bonner, J. M., Kory, N., Boland, S., Arczewska, A. A., Ralvenius, W. T., Akay, L., Lockshin, E., He, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4564 · Cited by 336
Li, H., Shi, W., Li, X., Hu, Y., Fang, Y., & Ma, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b09722 · Cited by 333
Recent advances in the synthesis of cyclopropanes
Wu, W., Lin, Z., & Jiang, H. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob01187g · Cited by 259
Meanwell, N. A. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00043 · Cited by 239
Ceramide is metabolized to acylceramide and stored in lipid droplets
Senkal, C. E., Salama, M. F., Snider, A. J., Allopenna, J. J., Rana, N. A., Koller, A., Hannun, Y. A., & Obeid, L. M. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.010 · Cited by 237
“(G and H) Total acylceramide levels were measured in livers (G) and LDs from the livers (H) of mice that were fed a control diet or oleate-enriched HFD for 8 weeks with or without PF-06424439 treatment.”
BackgroundMethodInfluentialLipid-Droplet Formation Drives Pathogenic Group 2 Innate Lymphoid Cells in Airway Inflammation
Karagiannis, F., Masouleh, S. K., Wunderling, K., Surendar, J., Schmitt, V., Kazakov, A., Michla, M., Hölzel, M., Thiele, C., & Wilhelm, C. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.003 · Cited by 170
Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication
Williams, C. G., Jureka, A. S., Silvas, J. A., Nicolini, A. M., Chvatal, S. A., Carlson-Stevermer, J., Oki, J., Holden, K., & Basler, C. F. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109479 · Cited by 142
Matias, M. I., Yong, C. S. M., Foroushani, A. B. K., Goldsmith, C., Mongellaz, C., Sezgin, E., Levental, K. R., Talebi, A., Perrault, J., Riviere, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109911 · Cited by 132
Chen, G., Harwood, J. L., Lemieux, M. J., Stone, S. J., & Weselake, R. J. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101181 · Cited by 128
Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations
Young, R. J., & Leeson, P. D. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00180 · Cited by 121
Rong, S., Xia, M., Vale, G., Wang, S., Kim, C.-W., Li, S., McDonald, J. G., Radhakrishnan, A., & Horton, J. D. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.011 · Cited by 102
“…DGAT2 inhibitor (PF-06424439) on TG synthesis and its ability to reduce SREBP-1-regulated lipogenic gene expression was shown by Futatsugi et al. 32 Here, we investigated the underlying molecular mechanism for this observation initially by treating animal models C57BL/6J and ob/ob mice and…”
Li, S., Wu, T., Lu, Y., Wang, J., Yu, F.-H., Yang, M., Huang, Y., Li, Z.-J., Wang, S.-L., Huang, L., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101596 · Cited by 94
DGAT2 Inhibition Alters Aspects of Triglyceride Metabolism in Rodents but Not in Non-human Primates
McLaren, D. G., Han, S., Murphy, B. A., Wilsie, L., Stout, S. J., Zhou, H., Roddy, T. P., Gorski, J. N., Metzger, D. E., Shin, M. K., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.004 · Cited by 86
Visible Light‐Mediated Cyclopropanation: Recent Progress
Chen, Z., Xie, Y., & Xuan, J. (2022) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202201066 · Cited by 76
Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis
Amin, N. B., Carvajal-Gonzalez, S., Purkal, J., Zhu, T., Crowley, C., Perez, S., Chidsey, K., Kim, A. M., & Goodwin, B. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav9701 · Cited by 74
Self-citationNisticò, C., Pagliari, F., Chiarella, E., Guerreiro, J. F., Marafioti, M. G., Aversa, I., Genard, G., Hanley, R., García-Calderón, D., Bond, H. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810102 · Cited by 59
“In the light of the above, by interfering with LD biosynthesis, we investigated the effects of a DGAT2 inhibitor (PF-06424439) [28,29] in X-ray-irradiated MCF7 breast cancer cells in order to potentially affect breast cancer cell radioresistance.”
BackgroundThe Role of Diacylglycerol Acyltransferase (DGAT) 1 and 2 in Cardiac Metabolism and Function
Roe, N. D., Handzlik, M. K., Li, T., & Tian, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-23223-7 · Cited by 57
A Modular Approach to the Synthesis of gem-Disubstituted Cyclopropanes
Harris, M. R., Wisniewska, H. M., Jiao, W., Wang, X., & Bradow, J. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b00899 · Cited by 55
Self-citationDe novo lipogenesis is essential for platelet production in humans
Kelly, K. L., Reagan, W. J., Sonnenberg, G. E., Clasquin, M. F., Hales, K. J., Asano, S. M., Amor, P. A., Carvajal‐Gonzalez, S., Shirai, N., Matthews, M. D., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00272-9 · Cited by 50
Self-citationAmin, N. B., Saxena, A. R., Somayaji, V., & Dullea, R. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.12.008 · Cited by 48
Progress of potential drugs targeted in lipid metabolism research
Liang, K., & Dai, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1067652 · Cited by 38
Specific Triacylglycerols AccumulateviaIncreased Lipogenesis During 5-FU-Induced Apoptosis
Li, N., Lizardo, D. Y., & Atilla‐Gokcumen, G. E. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00410 · Cited by 37
Futatsugi, K., Cabral, S., Kung, D. W., Huard, K., Lee, E. C. Y., Boehm, M., Bauman, J. N., Clark, R. W., Coffey, S. B., Crowley, C., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01200 · Cited by 36
Self-citationXu, C., Fu, Y., Liu, S., Trittipo, J., Lu, X., Qi, R. A., Du, H., Yan, C., Zhang, C., Wan, J., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001184 · Cited by 34
Direct Alkynylation of 3H-Imidazo[4,5-b]pyridines Using gem-Dibromoalkenes as Alkynes Source
Aziz, J., Baladi, T., & Piguel, S. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6b00406 · Cited by 32
Causes and Significance of Increased Compound Potency in Cellular or Physiological Contexts
Schwaid, A. G., & Cornella‐Taracido, I. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00762 · Cited by 29
Lipid droplets control mitogenic lipid mediator production in human cancer cells
Jovičić, E. J., Pucer, A., Eichmann, T. O., Koren, Š., Brglez, V., Jordan, P. M., Gerstmeier, J., Lainšček, D., Golob-Urbanc, A., Jerala, R., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101791 · Cited by 31
A novel role for DGATs in cancer
Hernandez‐Corbacho, M. J., & Obeid, L. M. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.12.001 · Cited by 28
Talebi, A., de Laat, V., Spotbeen, X., Dehairs, J., Rambow, F., Rogiers, A., Vanderhoydonc, F., Rizzotto, L., Planque, M., Doglioni, G., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02664-7 · Cited by 30
Discovery and Pharmacology of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors
Imbriglio, J. E., Shen, D., Liang, R., Marby, K., You, M., Youm, H. W., Feng, Z., London, C., Xiong, Y., Tata, J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01345 · Cited by 25
Tian, H., Liu, W., Zhou, Z., Shang, Q., Liu, Y., Xie, Y., Liu, C., Xu, W., Tang, L., Wang, J., et al. (2016) · Molecules · doi:10.3390/molecules21111543 · Cited by 25
“Attempts to introduce a gem-dimethyl group via the approach for the synthesis of 2h from 2b described above and a cyclopropyl group via sequential deprotonation ith LDA and quenching with 1,3,2-dioxathiolane-2,2-dioxide [34] at the α-position of carboxylate in 8l to prepare 8q and 8r, respectively, were unsuccessful b…”
MethodDevasthale, P. V., & Cheng, D. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00864 · Cited by 26
An Update on Direct C–H Bond Functionalization of Nitrogen-Containing Fused Heterocycles
Aziz, J., & Piguel, S. (2017) · Synthesis · doi:10.1055/s-0036-1590859 · Cited by 24
Chen, G., Zhou, G., Lotvola, A., Granneman, J. G., & Wang, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014682 · Cited by 25
“However, inhibition of FA re-esterification by DGAT1 or DGAT2 inhibitors PF04620110 (29) or PF06424439 (30) blunted the activation of AMPK by ABHD5 induction (Fig.”
BackgroundTertiary cyclopropyl carbagermatranes: synthesis and cross-coupling
Yang, S., Jiang, W., & Xiao, B. (2021) · Chemical Communications · doi:10.1039/d1cc02930d · Cited by 19
HProteome-BSite: predicted binding sites and ligands in human 3D proteome
Sim, J., Kwon, S., & Seok, C. (2022) · Nucleic Acids Res. · doi:10.1093/nar/gkac873 · Cited by 14
Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3
Huard, K., Londregan, A. T., Tesz, G. J., Bahnck, K. B., Magee, T. V., Hepworth, D., Polívková, J., Coffey, S. B., Pabst, B. A., Gosset, J. R., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01008 · Cited by 18
Self-citationDiscovery of novel class of histone deacetylase inhibitors as potential anticancer agents
El‐Awady, R., Saleh, E., Hamoudi, R., Ramadan, W. S. H., Mazitschek, R., Nael, M. A., Elokely, K. M., Abou-Gharbia, M. A., Childers, W. E., Srinivasulu, V., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116251 · Cited by 17
A General One-Pot Protocol for Hindered N-Alkyl Azaheterocycles from Tertiary Carboxylic Acids
Merchant, R. R., Lang, S. B., Tingting, Y., Zhao, S.-L., Qi, Z., Suzuki, T., & Bao, J. (2020) · Organic Letters · doi:10.1021/acs.orglett.0c01254 · Cited by 16
Multiplex fatty acid imaging inside cells by Raman microscopy
Uematsu, M., Kita, Y., Shimizu, T., & Shindou, H. (2020) · The FASEB Journal · doi:10.1096/fj.202000514r · Cited by 16
Gasparian, A. V., Aksenova, M. V., Oliver, D., Levina, E. M., Doran, R., Lucius, M. D., Piroli, G. G., Oleinik, N. V., Öğretmen, B., Mythreye, K., et al. (2022) · Molecular Biology of the Cell · doi:10.1091/mbc.e21-08-0420 · Cited by 16
“Inhibition of both enzymes by selective inhibitors of DGAT1, PF-04620110 (Dow et al. , 2011), and DGAT2, PF-06424439 (Futatsugi et al. , 2015), decrease the number and size of LDs in both COPA-depleted cells and control cells (Supplemental Figure S8).”
Pant, A., Belhaouari, D. B., Dsouza, L., & Yang, Z. (2024) · Journal of Virology · doi:10.1128/jvi.01103-24 · Cited by 16
Glicksberg, B. S., Amadori, L., Akers, N. K., Sukhavasi, K., Franzén, O., Li, L., Belbin, G. M., Akers, K. L., Shameer, K., Badgeley, M. A., et al. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0542-3 · Cited by 16
Takemoto, K., Fukasaka, Y., Yoshimoto, R., Nambu, H., & Yukioka, H. (2020) · Physiological Reports · doi:10.14814/phy2.14542 · Cited by 13
“We found that simultaneous administration of selective DGAT1 and DGAT2 inhibitors (Dow et al., 2011; Futatsugi et al., 2015) alters TAG absorption processes and, under high-fat diet (HFD) feeding, leads to watery diarrhea whereas either inhibition alone did not lead to diarrhea.”
BackgroundPhospholipase A2 group IVD mediates the transacylation of glycerophospholipids and acylglycerols
Breithofer, J., Bulfon, D., Fawzy, N., Tischitz, M., Zitta, C., Hartig, L., Grabner, G. F., Pirchheim, A., Hackl, H., Taschler, U., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100685 · Cited by 12
Futatsugi, K., Huard, K., Kung, D. W., Pettersen, J. C., Flynn, D. A., Gosset, J. R., Aspnes, G. E., Barnes, R. J., Cabral, S., Dowling, M., et al. (2016) · MedChemComm · doi:10.1039/c6md00564k · Cited by 12
Self-citationPabst, B. A., Futatsugi, K., Li, Q., & Ahn, K. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b01096 · Cited by 12
Self-citationFacile synthesis of 2-arylimidazo[1,2-a]pyridines catalysed by DBU in aqueous ethanol
Veer, B., & Singh, R. (2019) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2019.0238 · Cited by 12
Miglietta, S., Sollazzo, M., Gherardi, I., Milioni, S., Cavina, B., Marchio, L., Luise, M. D., Coadǎ, C. A., Fiorillo, M., Perrone, A. M., et al. (2025) · Open Biology · doi:10.1098/rsob.240151 · Cited by 12
Jacob, R. S., Dema, A., Chérot, H., Dumesnil, C., Cohen, S., Shalom, H. S., Rimon, N., Sibony-Nevo, O., Beck, G., Ainbinder, E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.19.599670 · Cited by 12
Jusović, M., Starič, P., Jovičić, E. J., & Petan, T. (2023) · Cancers · doi:10.3390/cancers15194857 · Cited by 12
“To find out if the observed LD accumulation in amino acid-free conditions is a consequence of de novo TAG synthesis and LD biogenesis, we treated cells with T863 and PF06424439, inhibitors of DGAT1 and DGAT2 enzymes, respectively [41,42].”
MethodTian, X., & Wu, L. (2025) · Chemical Science · doi:10.1039/d5sc01132a · Cited by 9
McPhee, M. J., Lee, J., Salsman, J., Pinelli, M., Cara, F. D., Rosen, K. V., Dellaire, G., & Ridgway, N. D. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100540 · Cited by 10
Yang, G., Du, X., Norris, D. M., Zadoorian, A., Zheng, Y., Gao, M., Brown, A. J., Grey, S. T., Zhou, C., & Yang, H. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2508912122 · Cited by 9
“To investigate this, we treated HeLa cells with DGAT inhibitors— PF - 04620110 (DGAT1) ( 11 ) and PF - 06424439 (DGAT2) ( 12 )— to block TAG synthesis and thereby prevent LD formation.”
Route Selection and Optimization in the Synthesis of Two Imidazopyridine Inhibitors of DGAT-2
Bader, S. J., Herr, M., Aspnes, G. E., Cabral, S., Li, Q., Bian, J., Coffey, S. B., Dowling, M., Fernando, D. P., Jiao, W., et al. (2018) · Organic Process Research & Development · doi:10.1021/acs.oprd.8b00005 · Cited by 8
Self-citationLee, Y., Hwang, Y., Kim, M., Jeon, H., Joo, S., Fang, S., & Kim, J. W. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0368 · Cited by 8
“We inhibited DGAT2 activity in HepG2 cell line via DGAT2 inhibitor [18], and shDGAT2 (Supplementary Fig.”
MethodDesign of Next-Generation DGAT2 Inhibitor PF-07202954 with Longer Predicted Half-Life
Filipski, K. J., Edmonds, D. J., Garnsey, M. R., Smaltz, D. J., Coffman, K. J., Futatsugi, K., Lee, J., O’Neil, S. V., Wright, A., Nason, D. M., et al. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00330 · Cited by 6
Self-citationGöker, H., & Özden, S. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.07.058 · Cited by 6
Pan, Y. (2021) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016414-00278 · Cited by 5
Zebrafish are resilient to the loss of major diacylglycerol acyltransferase enzymes
Wilson, M. H., Hensley, M. R., Shen, M., Lu, H.-Y., Quinlivan, V. H., Busch‐Nentwich, E. M., Rawls, J. F., & Farber, S. A. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107973 · Cited by 5
Assessing Nutraceuticals for Hepatic Steatosis: A Standardized In Vitro Approach
Palasantzas, V. E. J. M., Struik, D., Bos, T., Withoff, S., Fu, J., Jonker, J. W., & Hoogerland, J. A. (2026) · Nutrients · doi:10.3390/nu18030388 · Cited by 6
Smith, I. M., Rezhdo, O., Pan, M., Patel, M., Smith, N., Breault, D. T., Pelis, R. M., & Carrier, R. L. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00164 · Cited by 4
Catalytic enantioselective synthesis of cyclopropyl α-amino carboxylates and phosphonates
Beucher, H., Alahyen, I., Talbot, A., Poisson, T., & Jubault, P. (2024) · Organic Chemistry Frontiers · doi:10.1039/d4qo01139b · Cited by 4
Computational assessment of thioether isosteres
Barrows, R. D., Blacklock, K. M., Rablen, P. R., Khare, S. D., & Knapp, S. (2018) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2018.01.018 · Cited by 4
Singh, M., Bittner, S., Li, Y., Bittner, A., Han, L., Cortez, Y., Inayathullah, M., Arif, Z., Parthasarathi, R., Rajadas, J., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14528 · Cited by 4
“It is abundantly expressed in liver, acts upstream of DGAT1 and utilizes nascent DAG and de novo synthesized fatty acids as substrates to synthesize triglyceride destined for VLDL-TG assembly or intracellular storage, especially in the liver (steatosis) (Choi et al., 2007; Zammit, 2013; Futatsugi et al., 2015; Li et a…”
BackgroundRichards, S. E. V., Yang, M., Deik, A. A., & Ricq, E. L. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04463-2 · Cited by 3
“To further characterize the impact of serum diglyceride acyltransferases 1 and 2 (DGAT1 and 2) with PF-04620110 and PF-06424439 [39, 40].”
Micelle-Assisted C(sp2)–H Functionalization for C–Se and C–X Bond Formation in the Aqueous Medium
Chillal, A. S., Maurya, C., & Kshirsagar, U. A. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c03052 · Cited by 3
Direct ketone cyclopropanation enabled by Tebbe's reagent
Weinhold, T. D., Vins, J. C., & Frederich, J. H. (2026) · Tetrahedron Letters · doi:10.1016/j.tetlet.2026.156002 · Cited by 2
Devi, E. R., Sreenivasulu, R., Devi, K. M., Ramachandran, B., & Sireesha, M. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.146714 · Cited by 3
Singh, A. K., Chaube, B., Citrin, K. M., Fowler, J. W., Lee, S., Catarino, J. D. S., Knight, J., Lowery, S. C., Shree, S., Mahoney, K. E., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci197719 · Cited by 2
“In pre-clinical studies, Pfizer’s PF-06424439 decreased circulating TAG levels and reduced hepatic fat in rodents with MASLD (39).”
Waltl, L., Holubek, D., Speck, K., Wildermuth, R., Haut, F., Permann, S., Plangger, I., Steinborn, C., Rao, Z., D’Avino, D., et al. (2026) · Advanced Science · doi:10.1002/advs.76861 · Cited by 3
Therapeutic Approaches for Nonalcoholic Steatohepatitis ( NASH )
Glatthar, R., & Arch, R. H. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc274 · Cited by 1
Proteomics of lipid accumulation and DGAT inhibition in HepG2 liver carcinoma cells
Bhatt-Wessel, B. (2017) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17058194
“Effect of PF04 and PF06 on in vitro microsomal DGAT activity ....................... 52 3.2.2.2.2.”
BackgroundInfluentialHosseini, S. J., Emamian, S., Hassani, H., & Hamzehzadeh, N. D. (2020) · Russian Journal of Organic Chemistry · doi:10.1134/s1070428020120209
Zhang, W., & Zhai, R. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.740510745.793587739
PROGRESS IN SMALL-MOLECULE DGAT2 INHIBITORS
Filipski, K. J., Futatsugi, K., Dullea, R., Garnsey, M. R., & Smaltz, D. J. (2024) · Medicinal chemistry reviews · doi:10.1021/mc-2024-vol59.ch05
Self-citationTalebi, A., de Laat, V., Spotbeen, X., Dehairs, J., Rambow, F., Rogiers, A., Vanderhoydonc, F., Rizotto, L., Planque, M., Doglioni, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22655322
Talebi, A., de Laat, V., Spotbeen, X., Dehairs, J., Rambow, F., Rogiers, A., Vanderhoydonc, F., Rizotto, L., Planque, M., Doglioni, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22655328
Talebi, A., de Laat, V., Spotbeen, X., Dehairs, J., Rambow, F., Rogiers, A., Vanderhoydonc, F., Rizotto, L., Planque, M., Doglioni, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22655325
DGAT2: A key therapeutic target in lipid synthesis regulation and metabolic diseases
Cheng, J.-Y., Gu, H.-X., He, C.-H., Gong, W., Yang, K.-J., Liu, Y.-Y., Chen, Z., Jiao, Q.-B., Zhang, X.-W., & Luo, H. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179145
A live-cell medium-throughput assay for quantifying lipid accumulation in hepatocytes
Ko, M. C. D., Nowell, C. J., Turpin-Nolan, S. M., & Flynn, B. L. (2026) · Methods · doi:10.1016/j.ymeth.2026.10.006
BindingDB (2020) · UC San Diego · doi:10.7270/q2dj5j62
BindingDB (2024) · UC San Diego · doi:10.7270/q24q80fz
BindingDB (2016) · UC San Diego · doi:10.7270/q2f191hj
BindingDB (2022) · UC San Diego · doi:10.7270/q2bk1h5d
Metadata
- Authors
- Futatsugi, K., Kung, D. W., Orr, S. T. M., Cabral, S., Hepworth, D., Aspnes, G., Bader, S., Bian, J., Boehm, M., Carpino, P. A., Coffey, S. B., Dowling, M. S., Herr, M., Jiao, W., Lavergne, S. Y., Li, Q., Clark, R. W., Erion, D. M., Kou, K., Lee, K., Pabst, B. A., Perez, S. M., Purkal, J., Jorgensen, C. C., Goosen, T. C., Gosset, J. R., Niosi, M., Pettersen, J. C., Pfefferkorn, J. A., Ahn, K., & Goodwin, B.
- Affiliations
- Pfizer (United States) (US)
- Corresponding author
- Futatsugi, Kentaro
- Kung, Daniel W.
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-09-15
- Volume
- 58
- Issue
- 18
- Pages
- 7173-7185
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1640815882
- Cited by
- 88
- References
- 59
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 11 · 2023: 9 · 2022: 6 · 2021: 12 · 2020: 9 · 2019: 5 · 2018: 11 · 2017: 6 · 2016: 6 · 2015: 2
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- diacylglycerol acyltransferase 2, imidazopyridines, sp3 hybridization, N-glucuronidation, metabolic liability, dyslipidemia, liver lipids, circulating lipids, drug discovery
- MeSH terms
- Animals, Cyclopropanes, Dogs, Humans, Imidazoles, Male, Pyridines, Pyrrolidines, Receptors, LDL, Stereoisomerism, Structure-Activity Relationship, Rats, Sprague-Dawley, Mice, Knockout, Spodoptera, Hepatocytes, Dyslipidemias, Lipid Metabolism, Diacylglycerol O-Acyltransferase, Rats, Sf9 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.